BRIDGEWATER, N.J., Feb. 21, 2018 /PRNewswire/ -- Amneal
Pharmaceuticals has launched memantine hydrochloride
extended-release capsules, the company's AB-rated equivalent for
Namenda XR®, in 7 mg, 14 mg, 21 mg and 28 mg
strengths. The product is manufactured here in the United States in the company's recently
expanded Brookhaven, New York
facility.
Annual U.S. sales of Namenda XR® were $929 million, according to December 2017 QuintilesIMS market data.
About Amneal
Amneal Pharmaceuticals LLC, a privately-held company
headquartered in Bridgewater, New
Jersey, is one of the largest and the fastest growing
generics pharmaceutical manufacturers in the United States. Founded in 2002, Amneal now
has more than 5,000 employees in North
America, Asia and
Europe, working together to bring
high quality affordable medicines to patients worldwide. Amneal has
significantly expanded its portfolio of generic products to include
complex dosage forms in a broad range of therapeutic areas.
Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ:
IPXL) announced on October 17, 2017
that they have entered into a definitive business combination
agreement with the resulting combined company expected to create
the 5th largest generics business (by gross revenue) in
the United States. The transaction
is expected to close in the first half of 2018.
For more information, visit amneal.com.
All trademarks listed in this release are property of their
respective owners.
Product photo is available upon request.
CONTACTS:
|
|
|
|
Sales
|
Business
Development
|
Andy
Boyer
|
Apurva
Saraf
|
Executive Vice
President, Commercial Operations
|
Vice President,
Global Strategy & Corporate
|
908.409.6891
|
Development
|
andy.boyer@amneal.com
|
631.742.7674
|
|
apurvas@amneal.com
|
Media
|
|
Cheryl
Lechok
|
|
Media
Relations
|
|
203.613.1506
|
|
mediarelations@amneal.com
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/amneal-introduces-memantine-hydrochloride-extended-release-capsules-generic-for-namenda-xr-300601884.html
SOURCE Amneal Pharmaceuticals